| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |